NCT04098874View on ClinicalTrials.gov

Bupropion for the Prevention of Postpartum Smoking Relapse

PHASE4RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2026

Conditions
Postpartum Smoking Relapse
Interventions
DRUG

Bupropion Extended Release Oral Tablet

12 weeks postpartum of blinded study medication

DRUG

Placebo oral tablet

12 weeks postpartum of blinded placebo

Trial Locations (1)

55455

RECRUITING

University of Minnesota, Minneapolis

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Minnesota

OTHER